Cargando…

Ursolic Acid Improves Intestinal Damage and Bacterial Dysbiosis in Liver Fibrosis Mice

Liver fibrosis is a reversible process of extracellular matrix deposition or scar formation after liver injury. Intestinal damage and bacterial dysbiosis are important concomitant intestinal changes in liver fibrosis and may in turn accelerate the progression of liver fibrosis through the gut–liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Si-Zhe, Liu, Cong, Huang, Chen-Kai, Luo, Fang-Yun, Zhu, Xuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838135/ https://www.ncbi.nlm.nih.gov/pubmed/31736766 http://dx.doi.org/10.3389/fphar.2019.01321

Ejemplares similares

Ursolic acid improves the bacterial community mapping of the intestinal tract in liver fibrosis mice
por: Wan, Sizhe, et al.
Publicado: (2020)

Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis
por: Nie, Yuan, et al.
Publicado: (2021)

Protective Effect of Ursolic Acid on the Intestinal Mucosal Barrier in a Rat Model of Liver Fibrosis
por: Zhang, Wang, et al.
Publicado: (2019)

Interaction Mechanisms Between the NOX4/ROS and RhoA/ROCK1 Signaling Pathways as New Anti- fibrosis Targets of Ursolic Acid in Hepatic Stellate Cells
por: Huang, Chenkai, et al.
Publicado: (2019)

Ursolic Acid Protected Lung of Rats From Damage Induced by Cigarette Smoke Extract
por: Lin, Li, et al.
Publicado: (2019)

Ursolic acid reverses liver fibrosis by inhibiting interactive NOX4/ROS and RhoA/ROCK1 signalling pathways
por: Wan, Sizhe, et al.
Publicado: (2020)

Gut Microbial Dysbiosis Is Associated With Profibrotic Factors in Liver Fibrosis Mice
por: Wan, Sizhe, et al.
Publicado: (2020)

Potential Protective Effects of Ursolic Acid against Gamma Irradiation-Induced Damage Are Mediated through the Modulation of Diverse Inflammatory Mediators
por: Wang, Hong, et al.
Publicado: (2017)

Hypertension Is Associated With Intestinal Microbiota Dysbiosis and Inflammation in a Brazilian Population
por: Silveira-Nunes, Gabriela, et al.
Publicado: (2020)

Ursolic Acid Protects Neurons in Temporal Lobe Epilepsy and Cognitive Impairment by Repressing Inflammation and Oxidation
por: Liu, Kun-mei, et al.
Publicado: (2022)

Nanoformulations of Ursolic Acid: A Modern Natural Anticancer Molecule
por: Wang, Longyun, et al.
Publicado: (2021)

Canagliflozin Prevents Lipid Accumulation, Mitochondrial Dysfunction, and Gut Microbiota Dysbiosis in Mice With Diabetic Cardiovascular Disease
por: Wang, Xueliang, et al.
Publicado: (2022)

Synergistic effect of ursolic acid and piperine in CCl(4) induced hepatotoxicity
por: Biswas, Sayan, et al.
Publicado: (2021)

Bacterial Diversity in the Intestinal Mucosa of Dysbiosis Diarrhea Mice Treated with Qiweibaizhu Powder
por: Long, Cheng-Xing, et al.
Publicado: (2020)

Nanoparticles use for Delivering Ursolic Acid in Cancer Therapy: A Scoping Review
por: Miatmoko, Andang, et al.
Publicado: (2021)

Sex-Dependent Effects on Liver Inflammation and Gut Microbial Dysbiosis After Continuous Developmental Exposure to Trichloroethylene in Autoimmune-Prone Mice
por: Blossom, Sarah J., et al.
Publicado: (2020)

Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora
por: Liu, Xianzhi, et al.
Publicado: (2022)

Intestinal Dysbiosis in Young Cystic Fibrosis Rabbits
por: Liang, Xiubin, et al.
Publicado: (2021)

Jia-ga-song-tang protection against alcoholic liver and intestinal damage
por: Fang, Jiamin, et al.
Publicado: (2022)

Ursolic acid ameliorates CCl4‐induced liver fibrosis through the NOXs/ROS pathway
por: Gan, Dakai, et al.
Publicado: (2018)

Anti-inflammatory and antioxidant activity of ursolic acid: a systematic review and meta-analysis
por: Zhao, Man, et al.
Publicado: (2023)

Oleanolic Acid and Ursolic Acid Improve Bone Properties and Calcium Balance and Modulate Vitamin D Metabolism in Aged Female Rats
por: Cao, Sisi, et al.
Publicado: (2018)

The effectiveness of ursolic acid niosomes with chitosan coating for prevention of liver damage in mice induced by n-nitrosodiethylamine
por: Miatmoko, Andang, et al.
Publicado: (2022)

Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology
por: Luo, Xiaomin, et al.
Publicado: (2022)

The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis
por: Alhomrani, Majid, et al.
Publicado: (2017)

Ursolic Acid Regulates Cell Cycle and Proliferation in Colon Adenocarcinoma by Suppressing Cyclin B1
por: Yang, Minhui, et al.
Publicado: (2021)

Preventive Role of Salsalate in Diabetes Is Associated With Reducing Intestinal Inflammation Through Improvement of Gut Dysbiosis in ZDF Rats
por: Zhang, Xinrong, et al.
Publicado: (2020)

Oxidation of fish oil exacerbates alcoholic liver disease by enhancing intestinal dysbiosis in mice
por: Feng, Ruibing, et al.
Publicado: (2020)

Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis
por: Dai, Yun-Kai, et al.
Publicado: (2022)

Ethoxycarbonylmethyl ursolate
por: Yang, Wei, et al.
Publicado: (2008)

Tributyrin alleviates gut microbiota dysbiosis to repair intestinal damage in antibiotic-treated mice
por: Yang, Ning, et al.
Publicado: (2023)

Effects of Ursolic Acid on Intestinal Health and Gut Bacteria Antibiotic Resistance in Mice
por: Peng, Fang, et al.
Publicado: (2021)

Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
por: Zhang, Yubao, et al.
Publicado: (2021)

Mechanism Involved in Acute Liver Injury Induced by Intestinal Ischemia-Reperfusion
por: Jin, Binghui, et al.
Publicado: (2022)

Butyrate Improves the Metabolic Disorder and Gut Microbiome Dysbiosis in Mice Induced by a High-Fat Diet
por: Gao, Feng, et al.
Publicado: (2019)

Structural Characterization of Peptides From Huangjiu and Their Regulation of Hepatic Steatosis and Gut Microbiota Dysbiosis in Hyperlipidemia Mice
por: Shi, Ying, et al.
Publicado: (2021)

Emerging insights on intestinal dysbiosis during bacterial infections()
por: Pham, Tu Anh N, et al.
Publicado: (2014)

Comparison on different traditional Chinese medicine therapies for chronic hepatitis B liver fibrosis
por: Dai, Yun-kai, et al.
Publicado: (2022)

Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner
por: Zou, Hongye, et al.
Publicado: (2023)

The intervention effect of Amygdalus mongolica oil on the metabolomics and intestinal flora in pulmonary fibrosis
por: Li, Qian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vsn262352l7rn2c5j3m0moes8k